CDK 4/6 inhibitio
Interviews and expert commentary tagged “CDK 4/6 inhibitio” — the latest oncology research and clinical practice from the Audio Journal of Oncology.
Audio Journal of Oncology
Erica L. Mayer MD MPH: Adjuvant Abemaciclib: Start Low, then Dose Escalate in Early-stage HR+/HER2- Breast Cancer: TRADE Study Findings
Interview with Erica L. Mayer MD MPH, Director of Breast Cancer Clinical Research, Breast Oncology Program, Dana-Farber Cancer Institute, Boston, USA. With comment from: Pat Price MD, Imperial College
18 July 2025
9:29